Renal function in cardiac transplant recipients: Retrospective analysis of 133 consecutive patients in a single center

Clinical Transplantation

Volumn 11, Issue 1, 1997, Pages 1-8

  Tinawi, Mohammad ^a   Miller, Leslie ^a   Bastani, Bahar ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Cardiac transplantation; Cyclosporine; Nephrotoxicity; Renal failure

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; CYCLOSPORIN A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POTASSIUM;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEPHROTOXICITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; CHOLESTEROL; CREATININE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; MIDDLE AGED; POTASSIUM; RETROSPECTIVE STUDIES;

EID: 0031035801     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. MACOVIAK JS, OYER PE, STINSON EB, JAMIESON SW, BALDWIN JC, SHUMWAY NE. Four years experience with cyclosporine for heart and heart-lung transplantation. Transpl Proc 1985: 17:97.
2. FIRST MR. Renal allograft survival after 1 and 10 years: Comparison between pre-cyclosporine and cyclosporine data. Nephrol Dial Transpl 1993: 9: 90.
3. CALNE RY. European multicenter trial of cyclosporine in renal transplantation: 10 year follow-up. Transpl Proc 1993: 25: 527.
4. OPELZ G. Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathiopnne. Transpl Proc 1993: 25: 1289.
5. KAHAN BD. Cyclosporine. N Engl J Med 1989: 321: 1725.
6. MIHATSCH MJ, THIEL G, RYFFEL B. Histopathology of cyclosporine nephrotoxicity. Transpl Proc 1988: 20 (Suppl 3): 759.
7. MYERS BD, ROSS J, NEWTON L, LEUTSCHER J, PERLROTH M. cyclosporine-associated chronic nephropathy. N Engl J Med 1984: 311: 699.
8. MYERS BD. Cyclosproine nephrotoxicity. Kidney Int 1986: 30: 964.
9. MYERS BD, SIBLEY R, NEWTON L. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988: 33: 590.
10. BERTANI T, FERRAZZI P, SCHIEPPATI A, RUGGENENTI P, et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991: 40: 243.
11. MYERS BD, NEWTON L. Cyclosporine-induced chronic nephropathy: An obliterative microvascular renal injury. J Am Soc Nephrol 1991: 2: S45.
12. DISCHE FE, NEUBERGER J, KEATING J, PARSONS V, CALNE R, WILLIAMS R. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporine A. Lab Invest 1988: 58: 395.
13. SVENSON K, BOHMAN SO, HALLGREN R. Renal interstitial fibrosis and vascular changes: Occurence in patients with autoimmune diseases treated with cyclosporine A. Arch Intern Med 1986: 146: 2007.
14. YOUNG EW, ELLIS CN, MESSANA JM, JOHNSON KJ, LEICHTMAN AB, MIHATSCH MJ, et al. A prospective study of renal structure and function in psoriasis patients treated with cyclosporine. Kidney Int 1994: 46: 1216.
15. PEI Y, SCHOLEY JW, KATZ A, SCHACHTER R, MURPHY GF, CATTRAN D. Chronic nephrotoxicity in psoriatic patients treated with low-dose cyclosporine. Am J Kidney Dis 1994: 23: 528.
16. BERG KJ, FORRE O, BJERKHOEL F, AMUNDSEN E. DJOSELAND O, RUGSTAD HE, WESTRE B. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int 1986: 29: 1180.
17. BANTLE JP, PALLER MS, BOUDREAU RJ, OLIVARI MT, FERRIS TF. Long-term effects of cyclosporine on renal function in organ transplant recipients. J Lab Clin Med 1990: 115: 233.
18. LEWIS RM, JANNEY RP, GOLDEN DL, KERR NB, VANBUREN CT, KERMAN RH, KAHAN BD. Stability of renal allograft function associated with long-term cyclosporine immunosuppressive therapy: Five year follow-up. Transplantation 1989: 47: 266.
19. SLOMOWITZ LA, WILKINSON A, HAWKINS R, DANOVITCH G. Evaluation of kidney function in renal transplant patients receiving long-term cyclosporine. Am J Kidney Dis 1990: 15: 530.
20. LEWIS RM, VANBUREN CT, RADOVANCOVIC B. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: Serial renal function in heart and kidney transplant recipients. J Heart Lung Transpl 1991: 10: 63.
21. ALMOND PS, GILLINGHAM KJ, SIBLEY R, et al. Renal transplant function after ten years of cyclosporine. Transplantation 1992: 53: 316.
22. GONWA TA, MAI ML, PILCHER J, et al. Stability of long-term renal function in heart transplant patients treated with induction therapy and low-dose cyclosporine. J Heart Lung Transplant 1992: 11: 926.
23. LEWIS R, PODBIELSKI J, SPRAYBERRY S, et al. Stability of renal allograft glomerular filtration rate associated with long-term use of cyclosporine A. Transplantation 1993: 55: 1014.
24. BURKE JF, PIRSCH JD, RAMOS EL, et al. Long-term efficacy and safety of cyclosporine in renal transplant recipients. N Engl J Med 1994: 331: 358.
25. RUGGENENTI P, PERICO N, AMUCHASTEGUI S, FERRAZZI P, MAMPRIN E, REMUZZI G. Following an initial decline, glomerular filtration rate stabilizes in heart transplant patients on chronic cyclosporine. Am J Kidney Dis 1994: 24: 549.
26. VANBUREN DH, BURKE JF, LEWIS RM. Renal function in patients receiving long-term cyclosporine therapy. J Am Soc Nephrol 1994: 4: 517.
27. PATTISON JM, PETERSON J, KUO P, VAIANTINE V, ROBBINS RC, THEODORE J. The incidence of renal failure in one hundred consecutive heart-lung transplant recipients. Am J Kidney Dis 1995: 26: 643.
28. LOVERAS JJ, DURAND D, ADER JL, et al. Evolution of glomerular filtration rate and renal plasma flow in cyclosporine treated heart transplant recipients over a one year period. Transpl Proc 1993: 25: 2226.
29. TOMLANOVICH S, GOLBETZ H, PERLROTH M, STINSON E, MYERS BD. Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis 1986: 8: 332.
30. ROSS EA, WILKINSON A, HAWKINS RA, DANOVITCH GM. The plasma creatinine concentration is not an accurate reflection of the glomerular filtration rate in stable renal transplant patients receiving cyclosporine. Am J Kidney Dis 1987: 10: 113.
31. KASISKE BL. Creatinine excretion after renal transplantation. Transplantation 1989: 48: 424.
32. CECKA JM, CHO YW, TERASAKI PI. Analyses of the UNOS scientific renal trasnplant registry at three years - early events affecting transplant success. Transplantation 1992: 53: 59.
33. SALOMON D, BRUNSON M, VANSICKLER J, et al. A retrospective analysis of late renal graft function: Correlation with mean cyclosporine levels and lack of evidence for chronic cyclosporine toxicity. Transpl Proc 1991: 23: 1018.
34. AMEND W, SOSKIN T, VINCENTI F. et al. Long-term experience in primary cadaver renal transplants using cyclosporine. Clin Transpl 1990: 4: 341.
35. ROTH D, FERNANDEZ J, BURKE G, et al. Long-term double vs. triple immunosuppressive therapy for cadaveric renal recipients. J Am Soc Nephrol 1991: 2: 815A.
36. BASADONNA GP, MATAS AJ, GILLINGHAM KJ, et al. Early vs. late acute renal allograft rjection: Impact on chronic rejection. Transplantation 1993: 55: 993.
37. ALMOND PS, MATAS A, GILLINGHAM K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993: 55: 752.